Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03257657
Other study ID # 16-1932
Secondary ID UL1TR002535
Status Completed
Phase N/A
First received
Last updated
Start date July 31, 2017
Est. completion date February 22, 2018

Study information

Verified date March 2020
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Low-income and minority women are at increased risk for postpartum weight retention (i.e. retaining weight after pregnancy) and consequent persistent obesity. Women who are obese pre-pregnancy are 3-5 times more likely to gain weight, rather than lose weight, in the postpartum period than non-obese women. Aims for this pilot study are listed below:

Aim 1: To evaluate the feasibility and acceptability of a multi-component novel weight loss intervention delivered in a WIC setting to a population of low-income, predominantly racial/ethnic minority, obese, postpartum women.

Aim 2: To evaluate differences in weight change, diet, physical activity, self-efficacy, readiness to change, motivations to eat between intervention and control participants to determine preliminary intervention efficacy over a 12-week period.


Description:

Low-income and minority women are at increased risk for postpartum weight retention (i.e. retaining weight after pregnancy) and consequent persistent obesity. Women who are obese pre-pregnancy are 3-5 times more likely to gain weight, rather than lose weight, in the postpartum period than non-obese women.

Obesity science supports that weight loss interventions should be multi-component with regular points of contact. Building upon this, we have designed a multi-component intervention that considers the demands on women in the postpartum period and utilizes technology for both provider decision support and for virtual contact with participants. The intervention will address diet, physical activity, and social support through the use of in-person meetings with WIC staff, text messaging, phone coaching, self-monitoring, and Facebook.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date February 22, 2018
Est. primary completion date February 22, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Adult woman (=18 and <50 years old).

- Enrolled in WIC or with an infant enrolled in WIC.

- 3-12 months postpartum.

- A pre-pregnancy BMI of 25 - 40 kg/m2 (based on self-reported height and weight prior to pregnancy).

- Postpartum body mass index between 25 and 50 kg/m2.

- English- and/or Spanish-speaking.

- Owns a mobile phone with texting functionality in order to receive texts during the trial.

Exclusion Criteria:

- Health conditions impacting weight or ability to participate in a weight loss trial.

- Pregnancy or planned pregnancy in next 5 months.

- Any health problems or undergoing any treatments that might interfere with what participant eats or her ability to exercise.

- Medical provider recommendation to avoid exercise.

- Plans to be in a different geographic area within the next 5 months.

- Plans to stop coming to Aurora WIC in the next 5 months.

- Unable to give informed consent.

- Not able to read and understand English or Spanish at an 8th grade level.

- Not willing to create a Facebook account if they do not already have one.

- Asked to follow-up in < 3 months at most recent WIC visit.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Observation Group participants
Women in the observation group will receive usual WIC care, plus the opportunity to meet with a WIC Registered Dietitian (RD) at the 12 week visit. Written WIC materials on lifestyle recommendations will also be given to all observation group participants at the baseline visit. The Investigators will connect with the participant prior to the 12 week visit to make an appointment to meet with the WIC RD at that time.
Lifestyle group participants
Women in this group will receive typical WIC care plus the below described activities. The intervention will last 12 weeks.

Locations

Country Name City State
United States Aurora WIC Office Aurora Colorado
United States University of Colorado Aurora Colorado

Sponsors (3)

Lead Sponsor Collaborator
University of Colorado, Denver Colorado Clinical & Translational Sciences Institute, National Center for Advancing Translational Science (NCATS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of Recruitment The investigators plan to determine the feasibility of recruitment for a weight loss intervention by evaluating the rate of recruitment. Below describes number recruited/enrolled over 14 weeks of recruitment Once the final participant is recruited
Primary Attrition Rate of Subjects Enrolled in the Study The investigators will measure the number of dropouts/withdrawn once final participant has completed the 12 week visit. Once the final participant completes the 12 week visit
Primary Visit Attendance The investigators will measure lifestyle group participant attendance from enrollment through the 12-week visit. The number of participants who attended their visits is reported Baseline through Week 12, reported at Week 12
Primary Acceptability of a Weight Loss Intervention To determine acceptability, investigators will use qualitative interviews to ask open-ended questions on this topic including asking participants in the intervention whether they would participate again. The number of participants interviewed who indicated that they would participate again is reported. 12 weeks
Primary Evaluation of the Use of Phone Coaching Investigators will count the total number of times any participant used phone coaching. 12 weeks
Secondary Change in Weight Between Visits To determine differences in change in weight between the intervention and control groups, participants will be weighed on a scale in the Women, Infants, and Children (WIC) setting. Intervention group: Baseline, 12 weeks; Control group: Baseline and 12 weeks
Secondary Changes in Diet: Intakes Measured in Grams To determine differences in diet from baseline to 12 weeks between intervention and control groups, participants will complete the Block Fat-Sugar-Fruit-Vegetable Screener. This is a validated food screener for adults. Baseline and 12 weeks
Secondary Changes in Physical Activity To determine differences in total physical activity from baseline to 12 weeks between intervention and control groups, participants will complete an adapted version of the Pregnancy Physical Activity Questionnaire. This is a validated survey measure for physical activity. Baseline and 12 weeks
Secondary Changes in Diet and Physical Activity Self-efficacy To determine differences in self-efficacy from baseline to 12 weeks between intervention and control groups, participants will complete an adapted version of Eating Habits Confidence Survey and Exercise Confidence Survey.
Diet self-efficacy: Possible range: -32 to 32; Higher scores indicate improved self-efficacy.
Physical activity self-efficacy: Sticking to it scale: Possible range: -32 to 32; Higher scores indicate improved self-efficacy.
Making time scale: -12 to 12; Higher scores indicate improved self-efficacy.
Baseline and 12 weeks
Secondary Changes in Motivations to Eat To determine differences from baseline to12 weeks in motivations to eat between intervention and control groups, participants will complete the Eating Stimulus Index questionnaire.
Possible range = -92 to 92. Higher scores indicated improved lifestyle-related behaviors and motivations to eat.
Baseline and 12 weeks
Secondary Changes in Readiness to Change Investigators will evaluate any differences in readiness to change from baseline to 12 weeks between intervention and control groups by participants completing the Readiness to Change questionnaire. Possible range = -3 to 3; higher scores indicate greater change in readiness to change Baseline and 12 weeks
Secondary Changes in Diet: Intakes Measured in Cups To determine differences in diet from baseline to 12 weeks between intervention and control groups, participants will complete the Block Fat-Sugar-Fruit-Vegetable Screener. This is a validated food screener for adults. Fruit and vegetable intake changes are measured and reported in cups. Baseline and 12 weeks
Secondary Changes in Diet: kCal Intake To determine differences in diet from baseline to 12 weeks between intervention and control groups, participants will complete the Block Fat-Sugar-Fruit-Vegetable Screener. This is a validated food screener for adults. Baseline and 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2